Melanoma‐specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by epstein‐barr virus‐transformed B cells
- 18 July 1994
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 58 (1) , 69-79
- https://doi.org/10.1002/ijc.2910580113
Abstract
While much emphasis has been placed on the role of MHC class I‐restricted CDS+ T cells in the recognition of tumor‐specific antigens (Ag), evidence has accumulated that CD4+ T cells also play a critical role in the anti‐tumor immune response. However, little information exists on the nature of MHC class II‐restricted human tumor Ag. In an attempt to develop in vitro systems to characterize such Ag, we examined the ability of Epstein‐Barr virus(EBV) transformed B cells to present melanoma‐associated Ag to melanoma‐specific CD4+ cells. CD4+ T cells cultured from lymphocytes infiltrating a s.c. melanoma metastasis secreted TNF‐α and GM‐CSF specifically in response to autologous cultured melanoma cells expressing MHC class II molecules. These CD4+ cells also recognized MHC class II‐compatible EBV‐B cells pulsed with extracts of autologous melanoma cells, but failed to recognize EBV‐B cells pulsed with autologous non‐transformed cells or a variety of allogeneic tumors or normal cells. B cells pre‐fixed with paraformaldehyde were incapable of Ag presentation, suggesting that intracellular processing events were occurring. Antibody‐blocking studies defined HLA‐DR as the dominant if not exclusive restriction locus in this T‐B interaction, and HLA‐DR genocyping revealed DRBI 0404 to be the probable restriction element. In a second patient, a CD4+ T‐cell clone cultured from a melanoma lesion recognized autologous tumor Ag presented by autologous EBV‐B; no cross‐reactivity was observed with the other tumor system investigated, nor with autologous CD4+ T cells specific for tetanus toxoid. These findings demonstrate that tumor Ag can be processed and presented by EBV‐transformed B cells to MHC class II‐restricted tumor‐specific CD4+ T cells. They also provide a model system for direct identification of these tumor‐derived antigens.Keywords
This publication has 29 references indexed in Scilit:
- Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: Analysis by cytokine secretionCancer Immunology, Immunotherapy, 1993
- Specific Release of Cytokines by Lymphocytes Infiltrating Human Melanomas in Response to Shared Melanoma AntigensJournal of Immunotherapy, 1993
- Characterization of Lymphocytes Infiltrating Human Breast Cancer, Specific Immune Reactivity Detected by Measuring Cytokine SecretionJournal of Immunotherapy, 1992
- MHC‐restricted responses of CD8+ AND CD4+ T‐cell clones from regional lymph nodes of melanoma patientsInternational Journal of Cancer, 1992
- Human allogeneic melanoma-reactive T-helper lymphocyte clones: Functional analysis of lymphocyte-melanoma interactionsInternational Journal of Cancer, 1991
- DNA typing for class II HLA antigens with allele-specific or group-specific amplification. IV. Typing for alleles of the HLA-DR2 groupHuman Immunology, 1991
- Further DNA sequence microheterogeneity of the HLA-DR4/Dw13 haplotype group: Importance of amino acid position 86 of the DRβ1 chain for T-cell recognitionHuman Immunology, 1990
- Western Blot Analysis of Antigens on Melanoma Cells Recognized by Cytotoxic T CellsJNCI Journal of the National Cancer Institute, 1988
- Presentation of Soluble antigen to human T cells by products of multiple HLA-linked loci: Analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant epstein-barr virus-transformed lymphoblastoid cell linesHuman Immunology, 1987
- Homozygous typing cell-defined HLA-Dw specificities correlate better than serologically defined HLA-DR specificities with restriction elements for influenza virus-specific proliferative human T lymphocyte clonesHuman Immunology, 1985